Adding to Some Small-Cap Losers
On a slow news day we’re looking to build onto these three small-cap positions.
Who the Heck Is Aspen Aerogels? I’m Opening a Position
The small-cap aerogels firm is a compelling investment.
Raising Cash by Selling From These 2 Small-Cap Positions
Despite these planned sales, we’re not making a statement about the stocks involved.
After Moderna’s Big News, Here Are Three Biotechs to Watch
I’m following these lesser-known names amid biopharma’s move on Wednesday.
Sticking With This Ondas Price Target After Sales Guidance Update
The small-cap firm crushed expectations, though with some mixed results.
On a High Note: I’m Buying More Alto, Taking Aim at Another Stock
Here’s why I’m buying more Alto Ingredients, and looking to gun it for this stock.
Sticking With This Alto Ingredients Price Target Amid Turnaround
The small-cap firm enjoyed some strong results.
Buying More Rocket Lab After $397 Million Update
The aerospace firm has been awarded a significant contract by the U.S. Space Force.
The $10K Portfolio: Gunnin’ for Some More Smith & Wesson
As gun ownership appears to be on the rise, I’m adding to this weapons maker. Also, I’m eyeing an exit for this stock.